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Abstract.  Tyrosinated (Tyr) and detyrosinated (Glu) 
~t-tubulin,  species interconverted by posttranslational 
modification, are largely segregated in separate popu- 
lations of microtubules in interphase cultured cells. We 
sought to understand how distinct Tyr and Glu micro- 
tubules are generated in vivo, by examining time- 
dependent alterations in Tyr and Glu tubulin levels (by 
immunoblots probed with antibodies specific for each 
species) and distributions (by immunofluorescence) af- 
ter microtubule regrowth and stabilization. When 
microtubules were allowed to regrow after complete 
depolymerization by microtubule antagonists, Glu 
microtubules reappeared with a delay of ,',,25 min af- 
ter the complete array of Tyr microtubules had re- 
grown. In these experiments, Tyr tubulin immuno- 
fluorescence first appeared as an aster of distinct 
microtubules, while Glu tubulin staining first appeared 
as a grainy pattern that was not altered by detergent 
extraction, suggesting that Glu microtubules were 
created by detyrosination of "l'yr microtubules. Treat- 
ments with taxol, azide, or vinblastine, to stabilize 
polymeric tubulin, all resulted in time-dependent in- 
creases in polymeric Glu tubulin levels, further sup- 
porting the hypothesis of postpolymerization detyrosi- 
nation. Analysis of monomer and polymer fractions 
during microtubule regrowth and in microtubule 
stabilization experiments were also consistent with 
postpolymerization detyrosination; in each case, Glu 
polymer levels increased in the absence of detectable 
Glu monomer. The low level of Glu monomer in un- 
treated or noco~l_a~ole-treated  cells (we estimate that 
Glu tubulin comprises <2 % of the monomer pool) 
also suggested that Glu tubulin entering the monomer 
pool is efficiently retyrosinated. Taken together these 
results demonstrate that microtubules are polymerized 
from Tyr tubulin and are then rapidly converted to 
Glu microtubules. When Glu microtubules depolymer- 
ize, the resulting Glu monomer is retyrosinated. This 
cycle generates structurally, and perhaps functionally, 
distinct microtubules. 
T  YROSINATION of tubulin  is  an unprecedented post- 
translational modification.  In an ATP-requiring reac- 
tion, a tyrosine residue is added to the COOH termi- 
nus of  the ¢t-subunit oftubulin (Barra et al., 1973, 1974). This 
unusual reaction is carried out by a single, highly specific en- 
zyme, tubulin  tyrosine ligase  (Raybin and Flavin,  1977a; 
Murofushi, 1980). However, as encoded by most a-tubulin 
genes,  newly  synthesized  ¢t-tubulin contains  a  COOH- 
terminal tyrosine residue (e.g., Valenzuela et al., 1981; Vil- 
lasante et al., 1986). Thus, the primary modification is usu- 
ally the removal of the COOH-terminal tyrosine, and this is 
carried out by a second enzyme, tubulin carboxypeptidase 
(Argarana et al., 1978), which is also highly specific for ¢t-tu- 
bulin (Kumar and Flavin, 1981). Therefore, depending on the 
COOH-terminal residue of the ct-subunit, tubulin exists in 
two forms: tyrosinated or detyrosinated. (We have abbrevi- 
ated these Tyr  t or Glu, referring to their respective COOH- 
terminal residues.) 
1.  Abbreviations  used  in  this  paper:  CPA,  carboxypeptidase A;  Glu, 
detyrosinated; MSB, microtubule-stabilizing  buffer; TBS, Tris-buffered sa- 
line; Tyr, tyrosinated. 
The function of this unique posttranslational  modification 
of  tubulin remains unknown, although many studies have im- 
plicated it in alterations of the cytoskeleton, especially dur- 
ing differentiation. In Xenopus embryos, there is an increase 
in the amount of tubulin that can be tyrosinated (i.e., Glu 
tubulin)  during early development  (Preston  et al.,  1981). 
Similarly, an increase in the levels ofGlu tubulin accompany 
brain development in the chick (Rodriguez and Borisy, 1978) 
and the rat (Rodriguez and Borisy, 1979; Barra et al., 1980). 
In the study of Rodriguez and Borisy (1979), the increase in 
Glu tubulin paralleled a decrease in the specific activity of 
the ligase. Alterations  in the ligase activity have also been 
described during chick brain and muscle development (Dea- 
nin et al.,  1977). Consistent with these biochemical studies 
is a more recent study showing that immunoreactivity with 
a Tyr tubulin-specific mAb is progressively lost from paral- 
lel fiber axons in the cerebellar cortex during brain matura- 
tion (Cumming et al.,  1984). 
The rates  of posttranslational  tubulin  tyrosination  have 
been measured during shape changes in a number of cell 
types. Increased tyrosination rate has been observed in Chi- 
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cAMP (Deanin et al.,  1981) and after stimulation of rabbit 
and human leukocytes with chemoattractants (Nath et al., 
1981; 1982). The absolute rates of tyrosination measured in 
these studies suggest a relatively rapid turnover of COOH- 
terminal tyrosine. In cultured muscle cells, the half-life of 
COOH-terminal  tyrosine was  37  min,  whereas  tz-tubulin 
half-life was >48 h (Thompson et al.,  1979). Thus, altera- 
tions  in tyrosination (or  detyrosination) may effect rapid 
changes in the behavior of tubulin and microtubules. 
Tyr and Glu tubulin do not differ dramatically in their be- 
havior in vitro. The rate and extent of polymerization appear 
to be identical for each species (Raybin and Flavin, 1977b; 
Arce et al., 1978; Kumar and Flavin, 1982). Similarly, only 
subtle differences in the binding of microtubule-associated 
proteins have been described (Kumar and Flavin,  1982). 
Because of the importance of cellular localization for the 
function of tubulin, and the lack of any obvious difference 
in the in vitro behavior of the two species, we suspected that 
the function of tyrosination/detyrosination  might involve, in 
part, a differential localization of the two species.  Accord- 
ingly, we examined the distribution of the Tyr and Glu forms 
of tubulin using antibodies specific for each species  and 
found that they were distributed in a heterogeneous pattern 
in the microtubules of cultured cells:  some microtubules 
contained predominantly Tyr tubulin, while adjacent micro- 
tubules were composed primarily of Glu tubulin (Gundersen 
et al., 1984). This surprising result cannot be explained by 
a simple incompatibility of the two species to form copoly- 
mers,  since individual microtubules formed in vitro from 
mixtures of  Glu and Tyr monomers appear to reflect the com- 
position of the monomer pool (our unpublished observa- 
tions). Given the rapid turnover of microtubules in cultured 
cells (Saxton et al., 1984, Schulze and Kirschner, 1986), one 
would predict  a  rapid homogenization of the two forms, 
rather than the segregation we observed. 
Because  of  the  likelihood  that  structurally  different 
microtubules have functionally distinct roles, we wanted to 
determine the mechanism by which distinct Glu and Tyr mi- 
crotubules are created. In this report we use our specific anti- 
bodies to follow the progress of the posttranslational modifi- 
cations as they occur in their cellular context. We find that 
an array of distinct Tyr and Glu microtubules can be rapidly 
generated after the removal of agents that have completely 
disrupted the original array.  Combined with an analysis of 
the distributions of  the two species in the monomer and poly- 
mer pools and the effect of microtubule-stabilizing agents on 
the number of Tyr and Glu microtubules, our results estab- 
lish a  cyclic mechanism by which the two populations of 
microtubules can be created. Such a cycle may provide a par- 
adigm for understanding the rapid cytoskeletal changes in- 
volved in cellular morphogenesis. 
Materials and Methods 
Cell Culture and Treatments 
TC-7 cells, cultured in DME supplemented with 10 % FBS (growth medium) 
as previously described (Gundersen et al.,  1984), were seeded onto glass 
coverslips (for immunofluorescence) or plastic petri dishes (for preparation 
of SDS extracts) and allowed to grow for 2-3 d before commencing an ex- 
periment. Unless noted otherwise, all treatments involving cells were car- 
ried out at 37°C. All drugs were prepared as stock solutions in DMSO and 
added to growth medium such that the final DMSO concentration did not 
exceed 0.1%  (vol/vol). This concentration of DMSO had no effect on the 
distribution or levels of Tyr or Glu tubulin in cells (data not shown). 
For microtubole regrowth experiments, endogenous microtubules were 
first depolymerized by  treating  cells with one of the following:  4  IxM 
nocodazole (Aldrich Chemical Co., Milwaukee, Wl) for 4 h; 4 ktM Col- 
cemid (demecolcine; Sigma Chemical Co., St. Louis, MO) for 4 h; or 0°C 
for 1 h. For the cold treatment, growth medium at 0°C was added to the 
dish of cells; the dish was subsequently placed on an ice-water bath in the 
refrigerator. To permit the regrowth of microtubules, cells in nocodazole or 
Colcemid were rinsed twice with medium without added drugs and then 
placed into fresh growth medium. The time of addition of the second wash 
was taken as the zero time point. Cold treatment was reversed by removing 
the medium from the cells and adding fresh growth medium at 37°C.  The 
time of addition of the warm medium was taken as zero time in this case. 
After release, cells were placed in a 37°C incubator and, at various intervals, 
samples were prepared for immanofluorescence as described below. 
To stabilize microtubules, cells were treated with 5 ~tM taxol (a gift from 
Dr. Matthew Suffness, Natural Products Branch, Division of Cancer Treat- 
ment,  National  Cancer Institute),  10  lxg/ml  vinblastine sulfate (Aldrich 
Chemical Co.) or 20 mM sodium azide (Sigma Chemical Co.). The taxol 
and vinblastine treatments were performed in growth medium; the azide 
treatment was conducted in PBS containing 0.8 mM MgC12 and 0.7 mM 
CaClz (Dnlbecco's PBS) (Bershadsky and Gelfand,  1981). At appropriate 
times, cells were prepared for immunofluorescence or were dissolved in 
SDS sample buffer for immunoblot analysis (see below). 
Preparation of  Monomer and Polymer Fractions 
Monomer and polymer fractions were prepared from taxol-treated cells and 
from cells recovering from nocodazole treatment (both as described above). 
We initially followed the procedure of Caron et al.  (1985),  extracting the 
cells with 0.1% Triton X-100 in a microtubule stabilization buffer for 30 min. 
However, with this long extraction, we detected substantial conversion of 
Tyr to Glu tubnlin in the polymer fraction (data not shown). Accordingly, 
we modified the extraction conditions to limit this spontaneous conversion 
of Tyr to Glu tubulin. Cells on 100-mm plastic petri dishes were rapidly 
rinsed twice in microtubule-stabilizing buffer (MSB) (85  mM Pipes, pH 
6.93,  1 mM EG'I'A,  1 mM MgCl2, 2 M glycerol, and protease inhibitors 
[10 ~tg/ml aprotinin, 0.5 mM benzamidine, 5 ~tg/ml o-phenanthroline, and 
0.2 mM phenylmethylsulfonyl fluoride]), and then extracted with 1.6 ml of 
MSB containing 0.5 % (vol/vol) Triton X-100. After 3 rain, the Triton extract 
(monomer fraction) was gently removed to a graduated tube, the volume was 
noted and 1/5 volume of5x SDS buffer (10% SDS, 325 mM Tris-HCl, pH 
6.8, 30% glycerol, 250 mM DTT and 1 mM phenylmethylsulfonyl fluoride) 
was added. This sample was then boiled for 5 rain. The cytoskeletons re- 
maining on the #ate were carefully rinsed once with MSB and then soluhi- 
lized with 1.6 ml MSB plus 0.4 ml 5×  SDS buffer. After 5 rnin, this extract 
(polymer fraction) was removed from the plate and boiled 5 min. Samples 
were stored at  -70°C until analyzed by immunoblotting (see below). 
For most experiments, we visually checked the extent of  extraction. Cells 
on  coverslips were  extracted as  above,  but  instead of solubilizing the 
cytoskeletons, the extracted cells were fixed in -20°C methanol for 5 min 
and then processed for immunofluorescence. 
Indirect Immunofluorescence 
Cells grown on glass coverslips were fixed after the treatments described 
above by briefly rinsing them in Earle's balanced salt solution and then 
plunging them into -20°C methanol. As noted above, extracted cytoskele- 
tons were rinsed in MSB before methanol fixation.  The  fixed cells or 
cytoskeletons were rehydrated in 10 mM Tris-buffered saline, pH 7.4 (TBS), 
and if not used immediately, stored in TBS plus 0.1% sodium azide at 6°C. 
The fixed ceils (or cytoskeletons) were stained by double indirect im- 
munofluorescence using a rabbit peptide antibody specific for Glu tubulin 
(Gundersen et al., 1984) and a rat mAb (designated YLI/2) specific for Tyr 
tubulin (Kilmartin et al., 1982; Wehland et al., 1983). YL1/2 was the gener- 
ous gift of Dr. J. V. Kilmartin (Medical Research Council, Cambridge). Di- 
lutions were prepared in TBS with 10% normal goat serum. The Glu anti- 
body  was used at  a  1/50  dilution  of antiserum;  YLI/2  was  used  at  a 
1/250-1/500  dilution of an ascites fuid.  Staining of the Tyr tubulin array 
identical to that observed with YL1/2 was obtained with a rabbit peptide an- 
tibody specific for Tyr tubulin (Gundersen et al.,  1984) (data not shown). 
Second antibodies were fluorescein-conjugated goat anti-rat IgG and 
rhodamine-conjugated goat anti-rabbit IgG (obtained from Cooper Bio- 
medical Inc., Malvern, PA) and were used at 1/25 dilutions. No difference 
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and Tyr antibodies were done simultaneously,  as were subsequent incuba- 
tions with the second antibodies.  Fluorescence microscopy  and photogra- 
phy were performed as previously  described (Gundersen et al.,  1984). 
Immunoblots 
For  the  preparation  of  whole  cell  samples,  (from  taxol-,  azide-,  and 
vinblastine-treated cells),  cells were solubilized from 100-ram dishes in 2 
ml SDS sample buffer (2% SDS, 100 mM Tris-HCi, pH 6.8, 25% glycerol, 
0.1% bromphenol blue, 50 mM DTT, and 0.2 mM phenylmethylsulfonyl 
fluoride)  and boiled 5 rain. Samples  were subjected  to electrophoresis on 
7.5%  SDS polyacrylamide  gels (Laemmli,  1970) and then transferred to 
nitrocellulose sheets (2 h at 9 V/era in the transfer buffer of Towbin et al., 
1979). After the blocking step, blots were reacted with either the Tyr or Glu 
rabbit antibodies (both diluted  1/5,000), followed by a  1/1,000 dilution of 
horseradish peroxidase-conjugated goat anti-rabbit lgG (Cooper Biomedi- 
cal Inc.).  4-Chloro-l-naphthol was used as the chromagen. 
Quantification of ~r and Glu Tubulin 
To quantify the levels of Tyr and Glu tubulin, duplicate samples subjected 
to electrophoresis on SDS polyacrylamide  gels were immunoblotted along 
with varying amounts of porcine brain tubulin as a standard. The brain tubu- 
lin was prepared directly from brain extract by one-step DEAE chromatog- 
raphy,  without cycles of polymerization-depolymerization, essentially as 
described by Murphy (1982), and was >95% pure as judged by quantitative 
densitometry of SDS polyacrylamide gels.  After development,  immuno- 
blots were dried in the dark and then scanned with a video densitometer 
(model No. 620, Bio-Rad Laboratories, Richmond, CA) in the reflectance 
mode.  Because the intensity varied across individual bands, each band was 
scanned at six different positions and the values  were averaged.  For both 
Tyr and Glu tubulin, this assay was linear between 40 and 200 ng of tubulin 
and had a limit of sensitivity of 'x,20 ng. 
Brain tubulin is a mixture of Tyr and Glu tubulin (e.g., see Rodriguez 
and Borisy,  1979); therefore,  to use brain tubulin as an absolute standard, 
it was necessary to determine the levels of the tyro forms in brain tubulin. 
This was accomplished by determining the level of Glu immunoreactivity 
of brain tubulin before and after treatment with carboxypoptidase  A (CPA). 
CPA treatment removes the preexisting  COOH4erminal tyrosine residues 
without digesting the tubulin further (e.g., see Raybin and Flavin, 1977b) 
and thus yields pure Glu tubulin  that can be used to determine  the proportion 
ofGlu tubulin in brain tubulin. The Tyr tubulin is then assumed to represent 
the remainder of the tubulin. For convenience,  the CPA digestion was per- 
formed after samples of brain tubulin had been transferred to nitrocellulose 
from SDS polyacrylamide gels, although digestion of samples before elec- 
trophoresis gave identical results.  After the usual blocking step, nitrocellu- 
lose sheets were rinsed five times in 25 mM Tris-HCl, pH 7.5, 150 mM 
NaC1, and then incubated with rocking for 30 rain in 50 ml of 10 ~g/rni CPA, 
pretreated with phenylmethylsulfonyl  fluoride  (Worthington  Biochemical 
Corp./Cooper Biomedical  Inc., Malvern, PA), in the same buffer at 37°C. 
Complete conversion to Glu tubulin was confirmed by the absence of immu- 
noreactivity with the Tyr antibody. As determined with this assay, the level 
of Glu tubulin in DEAE brain tubulin was 52.4  5:  1.5% (n  =  3). 
Protein determination was  with a  modified  Lowry assay  (Geiger and 
Bessman, 1972) using BSA as a standard.  Samples in SDS buffer were pre- 
pared for protein assay as described by Tornqvist  and Belfrage  (1976). 
Results 
Throughout this study we have used TC-7 cells, an epithelial 
cell line derived from African green monkey kidney, whose 
distributions of Tyr and Glu tubulin have been described 
(Gundersen et al., 1984). As in many cultured cells, most of 
the microtubules in interphase TC-7 cells are stained only 
with an antibody specific for Tyr tubulin (Tyr antibody) (Fig. 
1 a), while a few are stained only with an antibody to Glu 
tubulin (Glu antibody) (Fig. 1 b). In addition some microtu- 
bules are stained brightly with both antibodies. We will refer 
to microtubules stained brightly with the Tyr antibody as Tyr 
microtubules and those stained brightly with the Glu anti- 
body as Glu microtubules. This classification is primarily a 
Figure  L  Distribution  of  Tyr  and  Glu  tubulin  in  TC-7  cells. 
Methanol-fixed cells were double stained with the rat Tyr and rabbit 
Glu antibodies followed by fluoreseein-conjugated goat anti-rat IgG 
and rhodamine-conjugated goat anti-rabbit IgG. Fluorescence im- 
ages of typical cells stained with (a) Tyr antibody and (b) Glu anti- 
body.  Bar, 20 Ixm. 
matter of convenience and by using it we do not mean to im- 
ply that there are microtubules that are composed of  only Tyr 
or only Glu tubulin. In fact, immunolocalization at the ultra- 
structural level suggests that nearly all microtubules contain 
some level of  each species (Geuens et al., 1986). Most of the 
results we report here have been confirmed with at least one 
other cell line in addition to the TC-7 cells; they are, thus, 
probably indicative of the behavior of microtubules in most 
cultured cells. 
Reappearance of ~/r and Glu Tubulin in Microtubules 
Regrown In Vivo 
To determine if the heterogeneous distribution of Tyr and 
Glu tubulin in cellular microtubules could be regenerated 
from a pool of monomeric tubulin, we conducted microtu- 
bule  regrowth  experiments in  vivo,  similar  to  those per- 
formed earlier by others  (e.g.,  Osborn  and  Weber,  1976; 
DeBrabander et al.,  1981a). We also reasoned that the pat- 
terns of recovery of the two forms might yield information 
as  to  how the  separate populations of microtubules  were 
created. To initiate the experiment, endogeneous microtu- 
bules were completely depolymefized by treating cells with 
either cold or drugs,  such as nocodazole or Colcemid; the 
resultant pool of tubulin monomer was then allowed to poly- 
merize by rewarming the cells or removing the drugs. Fig. 
2  shows an example of a  typical regrowth experiment, in 
which cells were first treated with nocodazole and then the 
nocodazole was washed away. The nocodazole treatment de- 
polymerized almost all cellular microtubules (Fig. 2, a  and 
b); a few short microtubule remnants were still observed in 
some cells (Fig. 2 b). In addition, a single dot near the nu- 
cleus was brightly stained with the Glu antibody and only 
dimly stained with the Tyr antibody (see also Fig,  3);  we 
have previously shown that this dot of staining corresponds 
to the centrosome (Gundersen and Bulinski, 1986a, b). The 
Tyr staining of nocodazole-treated cells was bright, but dif- 
fuse (Fig. 2 a), suggesting that the monomeric tubulin result- 
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growth  in  vivo  after the  re- 
lease of cells from nocodazole 
treatment.  Cells were treated 
with  nocodazole  to  depoly- 
merize  endogenous  micmtu- 
bules and then the nocodazole 
was  washed  away  to  permit 
microtubule  regrowth.  Cells 
were  fixed  at  the  indicated 
times and then double stained 
with the Tyr (a, c, e, g, and i) 
and Glu (b, d,f, h, and j) anti- 
bodies and appropriate second 
antibodies. (a and b) Cells af- 
ter 4  h  of 4  ~tM nocodazole 
treatment (O-time point); (c and 
d) 3 rain after nocodazole re- 
mo~; (e and f) 7 rain after no- 
codazole removal; (g and h) 30 
rain after nocodazole  removal; 
(i and j) 80 rain after nocoda- 
zole removal. Bar, 20 ltm. 
ing from the depolymerization of microtubules was primar- 
ily in the Tyr form. 
When cells were released from nocodazole, microtubules 
rapidly reformed. Initially, both nucleated (centrosomal) and 
nonnucleated  (free) microtubules  formed (Fig.  2  c),  but as 
growth continued the number of free microtubules decreased 
and  centrosomal  microtubules  predominated  (Fig.  2,  e,  g, 
and i). This result is similar to the regrowth of microtubules 
in vivo described earlier (Osborn and Weber,  1976;  DeBra- 
bander  et al.,  1981a);  however,  from the  standpoint  of the 
present  study,  the  most  striking  result  is  that  the  newly 
formed microtubules  were  stained  only with  the Tyr anti- 
body.  This was true for both the centrosomal and free mi- 
crotubules found 3 min after release from nocodazole (Fig. 
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microtubules observed 7 min after release (Fig. 2, e and  f). 
While the Tyr pattern did not change significantly during the 
remainder of the time course, other than to become more fo- 
cused to the centrosome (Fig. 2, g and i), the Glu staining 
of microtubules increased. Distinct Glu microtubules (i.e., 
those stained throughout their length with the Glu antibody) 
were first observed "~30 min after removal of nocodazole 
(Fig. 2 h). At this time, the array of Glu microtubules was 
similar to that observed in untreated cells (compare Fig. 2 
h with Fig.  1 b). However, the increase in Glu tubulin con- 
tinued for 1-2 h, surpassing the level in untreated cells (com- 
pare Fig. 2 j  with Fig.  1 b;  see also Fig.  10 below). 
In  contrast to  the  observed pattern  of recovery of Tyr 
microtubules, we did not observe an aster of Glu microtu- 
bules at any time during the recovery. Between the time when 
cells were devoid of Glu staining (up to 7 min) and the time 
when distinct Glu microtubules reappeared (at 30 min), we 
did observe a progressive increase in Glu staining; however, 
the pattern was grainy and diffuse, rather than confined to an 
Figure 3. Distribution of Tyr and Glu tubulin in detergent-extracted 
cells before and after microtubule regrowth. Cells were treated as 
in Fig. 2, but before fixation and staining, cells were extracted with 
Triton X-100 to remove monomeric tubulin (see text). Cells were 
then double stained with the "l'~yr  (a and c) and Glu (b and d) anti- 
bodies and appropriate second antibodies. (a and b) Nocodazole- 
treated cells  (0-time point);  (c and d)  10 win after nocodazole 
removal. Bar, 20 ttm. 
Table 1. Recovery Times for Tyr and Glu Microtubule 
Arrays 
Depolymerization  Reappearance of  Reappearance of 
treatment*  Tyr array¢  Glu array§  A(Glu-Tyr) 
min  min 
Nocodazole  (4 ttM, 
4 h)  7  30 
Cold (0°C,  1 h)  3  25 
Colcemid (4 lxM, 




* Cells were treated to depolymerize all endogenous microtubules, and then 
microtubules were allowed to regrow by removing the drug (nocodazole or 
Colcemid) or by adding warm growth medium. 
~t The time at which a Tyr-stained microtubule array, filling the cells, was first 
detected by immunofluoreseenee. 
§ The time at which distinct Glu-stained microtubules were first detected by 
immunofluorescence. 
aster of distinct, short microtubules. To determine whether 
this hazy staining was due to an increase in polymeric or 
monomeric Glu tubulin, we extracted cells recovering from 
nocodazole, under conditions that stabilize polymeric tubu- 
lin (see Materials and Methods and below). The extraction 
protocol used efficiently removed monomeric tubulin (com- 
pare Fig. 3 a  with Fig. 2 a) without noticeably perturbing 
the distribution of polymeric tubulin (compare Fig. 3 c with 
Fig. 2 e). In the example shown in Fig. 3, we have compared 
cells treated with nocodazole (0-min time point) (Fig. 3, a 
and b) with cells released from nocodazole for 10 min (Fig. 
3, c and d). A significant increase in the amount of Glu stain- 
ing between the 0 and 10 min time points can be seen. The 
grainy Glu staining is observed throughout the cell, appear- 
ing brighter in those areas of  high microtubule density (com- 
pare Fig. 3, c and d). Since these cells were extracted before 
fixation and staining, this suggests that the grainy Glu stain- 
ing  observed at  intermediate times  is  due to Glu  tubulin 
residing  in  microtubules.  Further experiments addressing 
this point are described below. 
We have also performed in vivo regrowth experiments in 
which cells were released from treatments with cold or Col- 
cemid, to determine if the timing and pattern of  reappearance 
of Tyr and Glu tubulin were unique to cells released from 
nocodazole. We found the same patterns of regrowth shown 
in Fig. 2 for release from either cold or Colcemid; however, 
the elapsed times required for recovery of the microtubule 
arrays were different (see Table I). Nonetheless, the time be- 
tween the reappearance of a fully regrown array of Tyr mi- 
crotubules (e.g., as shown in Figure 2 e) and the initial reap- 
pearance of distinct Glu microtubules (e.g., as shown in Fig. 
2 h) was very similar for all three types of regrowth experi- 
ments (Table I). This was the case even though the cytoplas- 
mic  array  of microtubules was  regenerated over different 
time courses, requiring up to 50 rain to form after Colcemid 
release (Table I).  Thus, Glu microtubules reappeared with 
a characteristic delay of ~25 min after the polymerization 
of Tyr microtubules. 
The in vivo microtubule regrowth experiments show that 
the normal distribution of Tyr and Glu microtubules can be 
rapidly generated from a pool of monomeric tubulin.  The 
preponderance of Tyr staining  in nocodazole-treated cells 
(Fig. 2 a) and also in the microtubules newly regrown after 
release from nocodazole (Fig. 2, c and e) both suggest that 
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distribution  of Tyr and  Glu 
tubulin.  Cells  were  treated 
with 5 IxM taxol, fixed at the 
indicated times, and then dou- 
ble stained with Tyr (a, c, and 
e) and Glu (b, d, and f) anti- 
bodies as descnbed in the leg- 
end  to  Fig.  1.  Fluorescence 
images from cells treatea with 
taxol for (a and b) 15 rain; (c 
and d) 60 rain; and (e and f) 
24 h. Bar, 20 #m. 
the pool of monomer is composed primarily of Tyr tubulin. 
This implies that Glu microtubules are created from pre- 
existing Tyr microtubules, rather than being formed de novo 
from monomeric Glu tubulin. The characteristic delay in the 
reappearance of Glu microtubules and the hazy pattern of 
Glu staining observed at intermediate times of regrowth sup- 
port this notion. A postpolymerization conversion of Tyr to 
Glu tubulin would also be consistent with the preference of 
tubulin carboxypeptidase for polymeric tubulin in in vitro 
assays (Kumar and Flavin, 1981; Arce and Barra, 1985). We 
have tested this putative mechanism in more detail in the ex- 
periments described below. 
Effect of  Microtubule-stabilizing  Agents on lyr 
and Glu Tubulin Distribution 
If Glu microtubules are formed by the detyrosination of Tyr 
microtubules, then agents that act to stabilize tubulin in the 
polymeric form should result in an increase in the level of 
Glu tubulin in microtubules. We tested this idea by treating 
cells with taxol, a drug that dramatically lowers the critical 
concentration for microtubule polymerization and  acts to 
stabilize microtubules in vivo (Schiff et al., 1979; Schiff and 
Horwitz, 1980; DeBrabander et al., 1981a, b). We observed 
a significant increase in the level of Glu staining in microtu- 
bules as early as 15 min after the addition of taxol to TC-7 
cells (compare Fig. 4 b to Fig.  1 b); little difference in the 
array of microtubules stained with the Tyr antibody could be 
detected at this time (Fig. 4 a). By 60 min of treatment the 
patterns of Tyr and Glu staining were virtually indistinguish- 
able (Fig. 4, c and d). In addition to its effects on the critical 
concentration of tubulin, taxol induces bundling of microtu- 
bules in vivo (Schiff and Horowitz, 1980;  DeBrabander et 
al.,  1981a, b). In the TC-7 cells used in this study, bundling 
was first noted at 60 min (Fig. 4, c and d); thus, the increase 
in Glu tubulin preceded the bundling effect of taxol. Simi- 
larly, microtubules not yet incorporated into bundles after 60 
min of taxol treatment still showed elevated levels of Glu 
staining. Longer taxol treatments (2-24 h; Fig. 4, e and f) 
resulted in increased bundling of microtubules as observed 
by others (DeBrabander et al.,  1981a, b), making it difficult 
to  discern  further  increases  in  Glu  tubulin  levels  in  in- 
dividual microtubules. Given the rapid increase in the level 
of Glu tubulin in response to taxol, we were surprised to find 
that there was still significant Tyr staining of taxol-induced 
microtubule bundles at 24 h  (Fig. 4  e). 
To confirm that taxol treatment resulted in an actual in- 
crease in Glu tubulin levels, we performed immunoblot anal- 
ysis of whole cell samples prepared at different times of taxol 
treatment.  Throughout this study we probed immunoblots 
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were prepared from cells treated with 5 I~M taxol for various times 
and then subjected to electrophoresis on SDS-polyacrylamide gels. 
A constant volume of extracted sample was loaded on each lane; 
this yielded equivalent protein loads as judged from Coomassie- 
stained gels (data not shown). After transfer to nitrocellulose, blots 
were probed with the rabbit Tyr (A) or Glu (B) antibodies. (Lanes 
1) Brain tubulin standard; (lanes 2) untreated cells; (lanes 3-7) cells 
treated with taxol for 15 min, 30 rain, 60 rain, 4 h, and 24 h, respec- 
tively. The position of the a-tubulin  band determined from Coo- 
massie-stained gels is shown on the right (a). 
with rabbit Tyr and Glu antisera at dilutions that yielded ap- 
proximately equal levels of immunoreactivity towards sam- 
pies of DEAE-purified brain tubulin (Fig. 5, A and B, lane 
1).  Since this brain tubulin is composed of 48 % Tyr and 
52 % Glu tubulin (see Materials and Methods), such a con- 
trol ensures that we are detecting the two forms at approxi- 
mately equal sensitivities. Results of  an immunoblot analysis 
of taxol-treated cells were consistent with the immunofluo- 
rescence data; Glu tubulin was detectably elevated within 15 
min  of taxol  addition,  and  longer treatments  resulted  in 
higher Glu tubulin levels until •4  h, when the level of Glu 
tubulin reached a plateau (Fig. 5 B). Little difference in the 
Tyr tubulin levels was observed during the taxol treatment 
(Fig. 5 A). The final level of Glu tubulin was approximately 
equal to that of Tyr tubulin and was maintained up to 24 h 
(Fig. 5, A and B, lanes 6 and 7). These results demonstrate 
that  immunofluorescence  staining  accurately  reflects  in- 
creases in Glu tubulin levels caused by taxol. 
The increase in Glu tubulin levels in the taxol-treated cells 
was significant for two reasons. (a) It showed that the level 
ofGlu mbulin in cells was not fixed, but could be altered rap- 
idly. (b) It further supported the hypothesis that Glu micro- 
tubules are generated after polymerization. Presumably, by 
stabilizing microtubules, taxol gives the tubulin carboxypep- 
tidase a longer time to work on the subunits of an individual 
micmtubule.  To extend these  results,  we investigated the 
effects of azide (in glucose-free medium) and vinblastine on 
the level and distribution of Tyr and Glu tubulin. Although 
these agents have dramatically different modes of action, 
they both effect  a stabilization of  tubulin in a polymeric form. 
Azide, by depleting cellular ATP, blocks an unidentified step 
in the in vivo depolymerization of microtubules (Moskalew- 
ski  et  al.,  1980;  Bershadsky  and  Gelfand,  1981; DeBra- 
bander  et  al.,  1981a), and  thus  acts  to  stabilize  cellular 
Figure  6.  Effect of azide on 
the distribution of  Tyr  and Glu 
tubulin.  Cells  were  treated 
with 20 mM sodium azide (in 
glucose-free  medium),  fixed 
at  various  times,  and  then 
double stained with the Tyr (a 
and c) and Glu (b and d) anti- 
bodies as in the legend to Fig. 
1.  lmmunofluorescence  im- 
ages of  calls treated with azide 
for (a and b) 30 min and (c and 
d) 3 h. Bar, 20 ~tm. 
Gundersen et al. Postpolymerization Detyrosination of Tubulin  257 Figure 7. Effect  of vinblastine on the distribution of Tyr and Glu tubulin. Cells were treated with 10 Ixg/ml  vinblastine sulfate, fixed at 
various times, and then double stained with Tyr (a-c) or Glu (d-f) antibodies (see Fig. 1). Immunofluorescence  images of cells treated 
with vinblastine for (a and d) 15 min; (b and e) 60 min; and (c and f) 12 h. Bar, 20 txm. 
microtubules. On the other hand, vinblastine initially de- 
polymerizes all the endogeneous microtubules and subse- 
quently drives the incorporation of the monomeric tubulin 
into  paracrystaUine  bundles  of  protofilamentous  tubulin 
(Dustin, 1984); thus, vinblastine also stabilizes tubulin in a 
polymeric form. 
As  shown in Figs.  6  and 7,  azide and vinblastine both 
caused an increase in the level of Glu staining. By 30 min 
of azide treatment the number of microtubules labeled with 
the Glu antibody was clearly elevated (Fig. 6 b; for compari- 
son, see untreated cells in Fig. 1 b). Little effect on the Tyr 
staining of microtubules was observed at this early time of 
treatment (Fig. 6 a).  Longer azide incubations resulted in 
further increases in Glu staining, so that by 2 h almost every 
microtubule was labeled with both the Glu and Tyr antibod- 
ies (data not shown) and by 3 h only the Glu antibody labeled 
microtubules brightly (Fig.  6,  c  and d).  As described by 
others (Moskalewski et al., 1980; Bershadsky and Gelfand, 
1981; DeBrabander et al., 1981a), we found that azide treat- 
ment stabilized microtubules against depolymerization by 
drugs (data not shown). 
Vinblastine also caused an increase in Glu staining; how- 
ever, the results are complicated slightly by the fact that the 
initial effect of vinblastine is to rapidly depolymerize all of 
the endogenous microtubules; by 15 min of vinblastine treat- 
ment very few microtubules remained (Fig. 7, a and d). The 
bright, but diffuse, staining of cells with the Tyr antibody at 
this  time  (Fig.  7  a),  analogous  to  the  Tyr  staining  of 
nocodazole-treated cells (Fig. 2 a), presumably reflects the 
presence  of monomeric  (Tyr)  tubulin.  Formation of the 
paracrystalline bundles  of tubulin  occurred  shortly  after 
microtubule breakdown; at 15 rain, the nascent crystals were 
stained brightly only with the Tyr antibody (Fig. 7, a and d). 
By 60 min, diffuse Tyr staining disappeared, and the para- 
crystals increased in size (Fig. 7 b), but they still did not ex- 
hibit significant Glu staining (Fig. 7 e). With longer vinblas- 
fine treatments (>4 h), all of the paracrystals showed increased 
staining with the Glu antibody (Fig. 7, c and f). 
As with the taxol treatment, we confirmed  that the increase 
in Glu staining of azide- and vinblagtine-treated cells was not 
the result of  unmasking of  Glu epitopes or some other artifact 
associated with the immunofluorescence  protocol. Immuno- 
blots of the azide time course (Fig. 8, A and B) showed an 
increase in the cellular level of  Glu tubulin by 30 min of azide 
treatment (Fig. 8 B, lane 4). Longer treatments resulted in 
further  increases  in  Glu tubulin levels,  which  paralleled 
decreases in the levels ofTyr mbulin so that by 3 h, Glu tubu- 
lin was the predominant form (Fig.  8).  An analogous in- 
crease in Glu tubulin levels was detected on immunoblots of 
vinblastine-treated cells; however, unlike taxol or azide treat- 
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pared from cells treated with 20 mM azide in glucose-fre.e  medium 
were analyzed by immunoblotting (as in legend to Fig. 5). Blots 
containing equivalent amounts of protein were probed with the rab- 
bit Tyr (A) or Glu (B) antibodies. (Lane 1) Untreated cells; (lanes 
2-8) cells treated with azide for 5 min,  15 min, 30 re.in, 60 min, 
2 h, 3 h, and 4 h, respectively. The position of the ¢t-tubulin band 
determined from Coomassie-stained gels is shown on the fight (a). 
ments,  the increase was significant only after long (>4 h) 
treatments (data not shown). Thus, for each treatment, the 
amount of  Glu and Tyr tubulin detected on immunoblots cor- 
roborated the levels of Glu and Tyr staining observed by 
immunofluorescence. 
Levels of Tyr and Glu Tubulin in Monomer 
and Polymer Pools 
Both  the  regrowth  and  stabilization  experiments strongly 
suggest that Glu tubulin is generated from Tyr tubulin while 
in the polymeric state.  However, an alternative hypothesis, 
that Glu monomer is first created from Tyr monomer and is 
then polymerized into (Glu) microtubules, although seem- 
ingly unlikely because it would require a complex sorting of 
Glu and Tyr tubulin to create distinct Glu and Tyr microtu- 
bules, was not ruled out. To examine critically the contribu- 
tions of these two possible pathways for the creation of Glu- 
rich microtubules, we have prepared monomer and polymer 
fractions of tubulin by detergent extraction of cells. By this 
approach, we were also able to assess the dynamics of Tyr 
and Glu tubulin in the monomer pool, information that could 
not be obtained from immunofluorescent staining. 
To separate the monomer and polymer pools of Tyr and 
Glu tubulin, we followed a protocol similar to that described 
by Caron et al. (1985), in which ceils are extracted with Tri- 
ton X-100 in a microtubule-stabilization buffer. However, we 
used a  higher Triton concentration and  shorter extraction 
times (see Materials and Methods) in order to limit the spon- 
taneous enzymatic conversion of Tyr to Glu tubulin that we 
observed during extraction (see below). As assessed by im- 
munofluorescence, the extraction conditions we used did not 
appear to alter appreciably the level of polymer or leave 
significant amounts of  unextracted monomer in the cells (see 
Fig. 3). The lack of contaminating monomer in the polymer 
pool is even more convincingly demonstrated by immuno- 
blots of cells treated with nocodazole to break down all of 
the microtubules; while no tubulin was detected in the poly- 
mer fraction (see Fig.  10, A and B, lane 11), quantification 
showed that 95 % of the total cell tubulin was recovered in 
the monomer pool. Whether polymeric tubulin was released 
into the monomer pool is  more problematic to ascertain; 
such a release could occur during the extraction by detach- 
ment  of cells,  by  fragmentation  of microtubules,  or  by 
dilution-induced depolymerization of labile  microtubules. 
As mentioned above, immunofluorescence of the extracted 
cells showed no dramatic loss of  microtubules during extrac- 
tion.  Also,  the lack of detectable tubulin in the monomer 
fraction prepared from taxol-treated cells (Fig. 9 A and B), 
which  would be expected to  contain predominantly poly- 
meric tubulin (Schiff et al.,  1979, 1980),  suggests that few 
cells  detached  during  the  extraction  and  that  stabilized 
microtubules were not fragmented or depolymerized. How- 
ever, at this time, we cannot rule out the possibility that de- 
polymerization of some labile microtubules occurred in ex- 
periments in which the cells were not previously exposed to 
taxol. 
Figure 9.  Immunoblot analy- 
sis of Tyr and Glu tubulin lev- 
els in monomer and polymer 
fractions prepared from taxol- 
treated  cells.  Monomer  and 
polymer fractions from taxol- 
treated cells were subjected to 
electrophoresis on SDS-poly- 
acrylamide gels, applying ex- 
tracts from the same number 
of cells to each lane of the gel 
(as verified  by Coornassie  stain- 
ing, each  lane of the  mono- 
mer blot and each lane of the 
polymer blot contained equal 
amounts of protein [data not shown]). After transfer to nitrocellulose, the blots were probed with the rabbit Tyr (A) or Glu (B) antibodies. 
(Lanes I and//) Whole-cell extract from untreated cells; (lanes 2) monomer fraction from untreated cells; (lanes 3-10) monomer fraction 
from cells treated with taxol for 2 min, 5 min, 10 rain,  15 min, 30 rain, 2 h, 6 h, and 12 h, respectively; (lanes 12) polymer fraction from 
untreated cells; (lanes 13-20) polymer fraction from cells treated with taxol for 2 rain, 5 rain,  10 rain,  15 min, 30 re_in, 2 h, 6 h, and 
12 h, respectively. The position of the a-tubulin band determined from Coomassie-stained gels is shown on the right (a). 
Gundersen et al. Postpolymerization  Detyrosination of Tubulin  259 Figure 10. Immunoblot analy- 
sis of Tyr and Glu tubulin lev- 
els in monomer and polymer 
fractions  during  microtubule 
regrowth  in vivo.  Cells  were 
treated with nocodazole to de- 
polymerize endogenous micro- 
tubules and then the nocoda- 
zole was washed out to permit 
microtubule regrowth. Mono- 
mer  and  polymer  fractions, 
prepared at the indicated times, 
were subjected to electropho- 
resis on SDS-polyacrylamide 
gels,  applying  extracts  from 
an equivalent number of cells 
to  each  lane  of the  gel  (as 
verified by Coomassie staining, each lane of the monomer blot and each lane of the polymer blot contained equal amounts of protein [data 
not shown]). To maximize the detection of Glu tubulin,  three times as much monomer or polymer extract was loaded on the gel to be 
stained with the Glu antibody compared with that to be stained with the Tyr antibody. After transfer to nitrocellulose, blots were probed 
with the rabbit Tyr (A) or Glu (B) antibodies and developed with peroxidase.  Monomer fractions from cells released from nocodazole 
treatment  for (lanes 1) 0 min;  (lanes 2) 2.5 rnin; (lanes 3) 5 rain; (lanes 4) 7.5 rain; (lanes 5)  10 rain; (lanes 6)  15 min;  (lanes  7) 30 
min; (lanes 8) 60 min; (lanes 9) 2 h; and (lanes 10) 3 h. (Lanes 11-20) Polymer fractions from cells released from nocodazole treatment 
for 0 min, 2.5 min, 5 min, 7.5 min, 10 min, 15 min, 30 min, 60 min, 2 h, and 3 h, respectively. The position of ct-tubulin determined 
from Coomassie-stained gels is shown on the right (tt). 
In our initial experiments, we sought to determine the lev- 
els of Tyr and Glu tubulin in monomer and polymer fractions 
prepared from untreated cells. To quantify the levels of the 
two forms, we scanned immunoblots (similar to those in Fig. 
9, A and B) by reflectance densitometry, using purified brain 
tubulin to generate a standard curve for each experiment (see 
Materials and Methods).  Using this method, we found that 
tubulin (the sum of the individual determinations of Tyr and 
Glu tubulin) comprised 3.5  +  0.5% (n =  5) of the total TC-7 
cell protein; other assays have yielded similar values in cul- 
tured cells (e.g.,  Hiller and Weber,  1978). 
The quantitative analysis of Tyr and Glu tubulin levels in 
whole cells and in monomer and polymer fractions is sum- 
marized in Table II. Glu tubulin comprised 4.9 % of the tubu- 
lin in whole cells and 4.5  +  4.3% and 16.2 +  3.1%  of the 
tubulin  recovered in the monomer and polymer fractions, 
respectively. The large standard deviation in the value for 
Glu monomer was the result of variability in its detection; 
in two of five experiments, we did not detect Glu monomer. 
These values for Glu monomer and polymer are clearly ar- 
tifactually elevated above those that must exist in the cell, as 
shown by the greater-than-twofold increase in the amount of 
Glu tubulin recovered in the combined monomer and poly- 
mer fractions (Table II). This increase in the total Glu tubulin 
level cannot be due to preferential loss of Tyr tubulin,  be- 
cause 94 % of the total cell tubulin was recovered in the two 
fractions (Table II). We attribute this extraction-induced in- 
crease in Glu tubulin to the activity of endogenous tubulin- 
specific carboxypeptidase; this enzyme, by generating Glu 
tubulin from Tyr tubulin, would increase Glu tubulin levels 
without altering the total amount of tubulin recovered. The 
level of monomeric Glu tubulin is probably further exagger- 
ated due to the breakdown of labile microtubules; in nocoda- 
zole-treated cells, which contained virtually no microtubule 
polymer, we did not detect Glu monomer, and we estimate 
an even lower level of Glu monomer (see Discussion). Thus, 
although we cannot assign absolute values for Glu tubulin 
levels in the two fractions, our determinations represent up- 
per limits and suggest that Glu tubulin is substantially en- 
riched in microtubules. 
As in untreated cells, the level of Glu monomer was very 
low in ceils treated with taxol (Fig. 9 B, lanes 3-10) and in 
cells recovering from nocodazole (Fig.  10 B, lanes 1-10); in 
fact, we did not detect Glu monomer in two trials of each 
Table II.  Tyr and Glu Tubulin Levels in Whole Cells and Monomer and Polymer Fractions 
Tubulin Composition 
Protein  Tubulin  Tyr  Glu 
Whole cell  (100)  (100)  95.1  +  0.9  4.9  :t: 0.9 
Monomer  61  +  2.2  36 +  4.1  95.5  +  4.3  4.5  +  4.3 
Polymer  39 +  2.2  64 + 4.1  83.8 5:3.1  16.2 +  3.1 
Total (monomer + polymer)  99 :h 7.0  94 +  5.5  87.3 +  6.8  233  +  35 
The values represent the mean  +  standard deviation from five separate experiments. 
Monomer and polymer values were calculated from the actual amounts recovered (e.g.,  %  monomer  =  monomer/monomer +  polymer  x  100). 
Total (monomer  +  polymer) values were the totals recovered in comparison to the whole cell level (e.g.,  % total (monomer  +  polymer) =  monomer  +  poly- 
mer/whole cell  ×  100). 
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zole for 4 h showed no Glu monomer even though virtually 
all of the cellular tubulin detectable was in monomeric form 
(Fig. 10, lanes 1). This suggests that upon depolymerization 
by nocodazole, the Glu tubulin that was originally in poly- 
mer was retyrosinated by tubulin tyrosine ligase. It also sup- 
ports the idea that our determination of Glu monomer in un- 
treated cells is artifactually elevated (see Discussion). 
The low level of Glu tubulin in the monomer pool suggests 
that  polymerization  of  Glu  tubulin  does  not  contribute 
significantly to the increases in Glu tubulin seen after taxol 
treatment or nocodazole release. The alternative hypothesis, 
the postpolymerization modification of Tyr to Glu tubulin, 
is further supported by the time course of Glu tubulin ac- 
emulation in polymer. In taxol-treated cells, the level  of 
monomeric tubulin decreased very rapidly, falling below de- 
tectable levels between 2 and 5 rain after taxol addition (Fig. 
9 A, lanes 2 to 10); a corresponding increase in polymeric 
tubulin,  while not obvious in Fig.  9 A, lanes 12-20, was 
documented by blots in which the protein loads were lower 
than in this comparison. Significantly, the increase in poly- 
meric Tyr tubulin occurred within 2 min of taxol addition 
(Fig. 9 A, lane 13); while a slight increase in Gin polymer 
was detected at 2 min, the majority of the increase occurred 
after much longer treatments (Fig. 9 B, lanes 12-20). 
The lag between the appearance of Tyr and Glu tubulin in 
microtubules was even more evident in cells released from 
nocodazole. As expected, the nocodazole treatment resulted 
in the complete depolymerization of microtubules; neither 
tubulin species was detected in the polymer fraction (Fig. 10, 
A and B, lane//) and quantitative densitometry showed that 
95 % of the cell tubulin was recovered in the monomer frac- 
tion. Upon nocodazole release there was a rapid polymeriza- 
tion of Tyr tubulin, so that by 5-10 rain a plateau level of Tyr 
polymer was reached (Fig.  10 A, lanes 12-20).  The mono- 
mer pool, which apparently consisted only of Tyr tubulin, 
decreased in a fashion complementary to the increase in the 
polymer fraction (Fig.  10 A,  lanes 1-10). Polymeric Glu 
tubulin was not detected until 5 min after release, and in- 
creased over the next hour (Fig. 9 B, lanes 12-18). Thus the 
major increase in Glu polymer levels occurred after the Tyr 
tubulin had already been incorporated into microtubules. In- 
terestingly, the level of Glu tubulin at time points ~>1 h after 
nocodazole release was greater than that seen in untreated 
cells (compare Fig.  10 B, lanes 18-20 with Fig. 9 B, lane 
//).  This was  also observed by immunofluorescence (see 
above). We have not determined precisely when cells recover 
from this "overshoot" in their content of Glu tubulin although 
the level appeared to drop after '~3 h (Fig.  10 B, lanes 19 
and 20). 
Discussion 
A Cyclic Model  for the Posttranslational 
7)~osination-Detyrosination of Tubulin 
Our results suggest that tubulin is alternately detyrosinated 
and retyrosinated in vivo, and that the modifications occur 
to distinct pools of tubulin. Taken together with previous ex- 
periments which demonstrated the in vitro substrate specific- 
ities of the ligase (Arce et al., 1978) and the carboxypeptidase 
(Kumar and Flavin, 1981; Arce and Barra,  1985), our data 
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Figure 11.  Cyclic model for  the  tyrosination-detyrosination of 
ct-tubulin. 
establish the cycle depicted in Fig. 11. We propose that Tyr 
monomer polymerizes to give Tyr microtubules; these are 
then acted upon by the tubulin carboxypeptidase to create 
Glu microtubules. When a Glu microtubule depolymerizes, 
the resulting Glu monomers are retyrosinated by the tubulin 
ligase to complete the cycle. As shown in Fig.  11, the poly- 
merization-depolymerization steps are envisioned to be re- 
versible; this reflects the ability of  both species to polymerize 
and depolymerize in vitro (our unpublished observations; 
Raybin and Flavin, 1977b; Kumar and Flavin, 1982). The cy- 
clic nature of  the model results from the restriction of  the two 
enzymatic activities to different pools of tubulin,  as dis- 
cussed in detail below. The possible cyclic nature of  tyrosina- 
tion-detyrosination was first recognized in a  treadmilling 
model proposed by Thompson (I982). 
That Tyr tubulin polymerizes to yield Tyr microtubules 
seems fairly obvious: Tyr microtubules are the predominant 
type in the cell, and only Tyr tubulin was detected in the 
microtubules that had formed at the earliest stages we exam- 
ined in regrowth experiments (e.g., after nocodazole release; 
see Figs. 2 and 10). It might be argued that recovery from 
drugs (or cold) is unusual in that the cells are in a state of 
convalescence; however, we have also observed that only Tyr 
microtubules are formed in the "natural" regrowth of inter- 
phase microtubules after mitosis (Gundersen and Bulinski, 
1986a).  Additional evidence for the polymerization of the 
Tyr form is that Tyr tubulin is the predominant monomeric 
species; in untreated cells, we found that Glu tubulin repre- 
sented only 4.5 % of  the monomeric tubulin and even this low 
value is likely to be an overestimate. Two sources could ar- 
tifactually contribute to an overestimate of the level of Glu 
monomer: the extraction-induced conversion of Tyr to Glu 
monomer and the depolymerization of labile microtubules 
containing Glu tubulin. Although it is clear that Tyr polymer 
is converted to Glu polymer upon extraction (more Glu tubu- 
lin was recovered in the polymer fraction than originally ex- 
isted in the whole cell [Table U]), we do not have evidence 
that an analogous conversion occurred in the monomer frac- 
tion. In fact, the lack of detectable Glu tubulin in the mono- 
mer fraction prepared from nocodazole-treated cells, which 
contained 95 % monomeric tubulin, suggests that conversion 
of the monomeric tubulin pool did not occur at a significant 
rate  during  extraction.  The  depolymerization  of  labile 
microtubules is more likely to contribute to the Glu mono- 
mer levels that we have determined. Although we did not de- 
tect a dramatic breakdown of microtubules in extracted cells 
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percentage  of  the  microtubule  polymer  would  have  a 
significant effect on the Glu tubulin levels in the relatively 
smaller pool of monomeric tubulin.  For example, if one- 
third of the recovered monomeric tubulin came from the 
breakdown of polymeric tubulin,  which  contained "~B% 
Glu tubulin, then all the Glu tubulin in the monomer pool 
(4.5 %) could be accounted for by microtubule depolymer- 
ization. 
Because it is difficult to correct for breakdown of labile 
microtubules during extraction, we feel that a better estimate 
of the actual level of Glu monomer can be obtained from 
nocodazole-treated cells, which are virtually devoid of mi- 
crotubules. In two separate experiments, we detected no Glu 
monomer in cells treated with nocodazole (see Fig.  10 B); 
based on our sensitivity of detection of Glu tubulin on immu- 
noblots (20 rig) and the amount of monomeric tubulin loaded 
on the immunoblots (1.1-1.4 Ixg), we estimate that Glu tubu- 
lin is <2 % of the monomeric tubulin. 
The second step in our proposed cycle is the postpolymer- 
ization conversion of Tyr to Glu tubulin, presumably carried 
out by the enzyme tubulin carboxypeptidase. Several groups 
have detected carboxypeptidase activity toward tubulin in 
brain extracts (Argarana  et al.,  1978; Kumar and Flavin, 
1981; Arce and Barra, 1983; 1985), yet this enzymatic activ- 
ity had not been reported in material from sources other than 
brain tissue. The increase in Glu tubulin and the decrease in 
Tyr tubulin in the extracted cells (Table II) is direct evidence 
that tubulin carboxypeptidase is active in the TC-7 cells used 
in this study. Characterization of the partially purified brain 
enzyme has revealed that the enzyme is highly specific for 
tubulin (Kumar and Flavin, 1981), that its activity co-purifies 
with microtubules (Arce and Barra, 1983), and that it prefers 
polymeric over monomeric tubulin as a  substrate (Kumar 
and Flavin,  1981; Arce and Barra,  1985). 
Evidence of  postpolymerization  modification of  Tyr to Gin 
tubulin in vivo was obtained in two types of experiments. 
Using three different agents, each with a distinct mechanism 
of interfering with microtubule depolymerization, we ob- 
served an accumulation of Glu tubulin in microtubules. Al- 
though azide is likely to have profound consequences for 
other cellular components, including the inhibition of the 
ATP-requiring ligase (Raybin and Flavin, 1977a), taxol and 
vinhlastine interact specifically with tubulin and have mini- 
mal effects on other cellular processes (Dustin, 1984). Addi- 
tionally, the taxol and azide experiments demonstrate that all 
microtubules are potential substrates for the carboxypepti- 
dase, since both treatments led to substantial levels of Glu 
tubulin in every microtubule. This result is important be- 
cause it establishes that postpolymerization detyrosination is 
not limited to a subset of the microtubules. In the second set 
of experiments we directly observed the appearance of Glu 
tubulin in microtubules regrown after release from nocoda- 
zole, Colcemid, or cold treatments. In each case, the reap- 
pearance ofGlu microtubules was delayed "~25 rain after the 
reappearance of  Tyr microtubules. Analysis of monomer and 
polymer fractions of cells released from nocodazole showed 
that the newly polymerized microtubules did not contain de- 
tectable Glu tubulin (again, reflecting the preponderance of 
Tyr tubulin in the monomer pool); only later did Glu tubulin 
begin to accumulate in microtubules. This analysis addition- 
ally demonstrated that microtubules at steady-state are sus- 
ceptible to the carboxypeptidase; a plateau in the level of 
polymeric tubulin was  reached by 5-10 rain after release 
from nocodazole, while the accumulation of polymeric Glu 
tubulin continued for at least 60 min (Fig.  10). 
In both the taxol and nocodazole release experiments, we 
found that Glu tubulin did not appear at measurable levels 
in the monomer pool (Figs. 9 and 10). This limits the possi- 
bility that monomeric Glu tubulin is polymerized at specific 
times or locations to create a  population of Glu microtu- 
bules. Additional evidence discounting this possibility is the 
pattern of Glu recovery we detected by immunofluorescence 
in ceils released from depolymerizing conditions; instead of 
the sudden reappearance of microtubules stained with Glu 
antibody, we observed increasing levels of grainy Glu stain- 
ing in polymer until the stage at which distinct Glu microtu- 
bules were detected. The grainy pattern of Glu staining pre- 
sumably represents increasing detyrosination of  Tyr subunits 
along microtubules. It remains a formal possibility that the 
Glu tubulin in microtubules is created, in part, by a coupled 
mechanism in which Tyr tubulin is converted to Glu tubulin 
as the subunit adds onto the end of a microtubule. However, 
the simultaneous presence of microtubules with different lev- 
els of Glu tubulin, yet with a constant level along their length 
(Geuens  et  al.,  1986),  is  more  consistent  with  a  post- 
polymerization modification of Tyr microtubules than with 
a coupled polymerization-conversion mechanism. It is also 
clear from taxol treatment of cells that Tyr tubulin can be 
converted to Glu tuhulin in the virtual absence of any mono- 
mer (see Fig. 9). 
Can the Glu tubulin in microtubules be retyrosinated while 
residing in polymer? Currently, we do not have direct evi- 
dence ruling out this possibility; but it is clear that on bal- 
ance, the net direction is toward the formation ofGlu tubulin. 
In addition, the ligase has not been found to use polymeric 
tubulin as a substrate in in vitro assays (Arce et al.,  1978). 
Although  the  lack  of  complete  detyrosination  of  taxol- 
stabilized microtubules or vinblastine paracrystals of tubulin 
(even after 24 h) may result from inaccessibility of the bun- 
died microtubules to the carboxypeptidase, it could also be 
due  to  retyrosination of polymer.  In  azide  treatments  in 
which the ligase is presumably inhibited, nearly complete 
detyrosination was observed in as little as 4 h. 
At this time, we have only limited evidence for the other 
half of the cycle, namely the breakdown of Glu microtubules 
and the subsequent retyrosination of the resulting Glu mono- 
mer. Nonetheless, these steps can be inferred from existing 
information. For example, since all interphase microtubules 
undergo  depolymerization  at  the  onset  of  mitosis  (see 
Dustin,  1984),  it is  clear that,  at  least  at  this  time,  Glu 
microtubules would also be broken down. From the rate of 
formation of Glu microtubules after microtubule regrowth, 
('~30 rain to regenerate an array of Glu microtubules similar 
to that seen in an interphase cell), one would predict that un- 
less Glu microtubules break down, they should accumulate 
during interphase. Although there is significant cell-to-cell 
variability in the number of Glu microtubules in a population 
of cells (Fig.  1 b; Gundersen et al.,  1984),  we have not ob- 
served dramatic differences in the number of Glu microtu- 
bules over the cell cycle (our unpublished observations). 
Evidence for the last step in the cycle, the retyrosination 
of Glu monomer, is also indirect. The lack of significant ac- 
tivity of the ligase toward polymeric tubulin (Arce et al., 
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lin in vitro (Raybin and Flavin,  1977a) predict that this en- 
zyme would be active in retyrosinating monomeric Glu tu- 
bulin  in  vivo.  An  ATP-dependent tyrosine ligase  activity 
specific for tubulin has been found in extracts of brain and 
cultured cells, as well as in many other sources (Raybin and 
Flavin, 1977a; Deanin et al., 1977; Preston et al., 1979, 1981). 
In addition, we observed no Glu monomer after depolymer- 
ization of microtubules (see Fig.  10); since these cells con- 
tained detectable Glu tubulin in polymer before depolymer- 
ization, this suggests that Glu tubulin is retyrosinated upon 
entering the monomer pool. Furthermore, we have observed 
the rapid disappearance of Glu monomer in cells microin- 
jected  with  Glu  tubulin  (Webster  et  al.,  1987).  Thus, 
retyrosination of Glu monomer is a  normal component of 
this cycle. Coupled with results above, these data suggest that 
the breakdown of Glu microtubules and the subsequent re- 
tyrosination do contribute to the cycle as depicted in Fig.  11; 
however, further experimentation will be necessary to com- 
pletely establish their significance and relationship to the 
other steps in the cycle. 
Can this cycle account for the observed distribution of Tyr 
and Glu microtubules? As mentioned above, we estimate that 
a Glu microtubule can be created in as little as 20 min. Given 
a half-life of microtubules in tissue culture cells of 5-20 min 
(Saxton et al.,  1984;  Schulze and Kirschner,  1986),  one- 
eighth to one-half of the microtubules present at any instant 
would have accumulated enough Glu tubulin to have become 
a "Glu microtubule" Estimates of the percentage of the total 
microtubules that are of the Glu type in an average TC-7 cell 
(r~15-20%;  our  unpublished  observations)  are  squarely 
within this range. Since every microtubule is a potential sub- 
strate for the carboxypeptidase (see above), the random de- 
tyrosination of microtubules, coupled with stochastic break- 
down  of microtubules and  efficient retyrosination of Glu 
tubulin entering the monomer pool, are sufficient to explain 
the distribution of Tyr and Glu microtubules we have ob- 
served. 
What is the significance of such a cycle for tubulin func- 
tion? In considering the possibilities, it is useful to recall the 
levels of the various species in vivo: Tyr monomer, '~35% 
(of total cell tubulin); Tyr polymer, '~55%;  Glu polymer, 
~10%; and Glu monomer, probably <1% (based on the level 
determined  from  nocodazole-treated cells).  As  discussed 
above, these levels of Glu monomer and polymer are likely 
to be overestimates; nonetheless, even if the Glu levels are 
accurate, it is clear that the cycle is inefficient in generating 
two species of monomer that might differ in either their abil- 
ity to polymerize, their degradation rates, or their effect on 
the  autoregulation of tubulin  synthesis  (Cleveland et al., 
1981). In fact, the cycle is efficient in maintaining the mono- 
mer pool as a  single species, due to the apparently rapid 
retyrosination of Glu tubulin entering the pool. 
If the role of this cycle is not to generate different mono- 
meric species, then the most likely possibility remaining is 
that it is used to generate polymers with distinct biochemical 
properties.  Although  we have not made a  detailed analy- 
sis,  the  results  of the  present study already point to one 
significant difference between Tyr and  Glu microtubules: 
most or all Tyr microtubules are growing, while many Glu 
microtubules are not. This conclusion is based on the follow- 
ing considerations. In two previous studies, nearly all cellu- 
lar microtubules (hence, most of the Tyr microtubules) were 
found to add microinjected tubulin subunits to their ends dis- 
tal to the centrosome (Soltys and Borisy, 1985; Schulze and 
Kirschner,  1986).  In the former study,  all of the growing 
microtubules were identified with a  Tyr-specific antibody, 
demonstrating that these were,  in fact, Tyr microtubules. 
Our conclusion that many Glu microtubules are not growing 
stems from two experimental observations: (a) the existence 
of Glu microtubules that are stained along their entire length 
only with the Glu antibody; and (b) our determination that 
Tyr tubulin is the predominant species in the monomer pool. 
Any Glu microtubules that are growing would be expected 
to contain segments  at  their distal  ends  that  consisted of 
>98 % Tyr tubulin (based on our estimate that <2 % of the 
monomer pool is Glu tubulin). 
How can the property of  not adding subunits and, perhaps, 
other properties ofGlu microtubules, be translated into func- 
tional differences between Glu and Tyr microtubules? The 
possibilities can be divided into two categories, depending 
upon the relative stabilities of the Glu and Tyr classes of 
microtubules. If Glu microtubules are less stable than Tyr 
microtubules,  postpolymerization detyrosination could be 
involved in the control of  microtubule depolymerization. On 
the  other  hand,  if  Glu  microtubules  are  more  stable, 
detyrosination could allow these less dynamic microtubules 
to perform a "differentiated" function (e.g., struts for main- 
tenance of cell shape,  different tracks  on  which  vesicles 
could move, etc.). As discussed above, the number of Glu 
microtubules and their rate of formation are consistent with 
a role for detyrosination in depolymerization; however, at 
this time we have no evidence that detyrosination is neces- 
sary or even that it promotes depolymerization. Evidence 
that supports a role of detyrosination of microtubules in one 
of the functions of differentiated microtubules is the finding 
that the specialized assemblies of microtubules (e.g., axo- 
nemes,  neurites,  marginal  bands)  in  differentiated  cells 
characteristically  contain  elevated  levels  of  Glu  tubulin 
(Gundersen and Bulinski, 1986b). Also, preliminary studies 
on interphase microtubules in cultured cells have shown that 
Glu microtubules are relatively more stable against the ac- 
tion of some microtubule-depolymerizing agents  (our un- 
published results). In any case, the cycle established in the 
present study equips cells with a mechanism for generating 
and maintaining distinct populations of microtubules with 
biochemically different properties. 
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